COVA4231
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 14, 2018
COVA4231, a potent CD3/CD33 bispecific FynomAb with IgG-like pharmacokinetics for the treatment of acute myeloid leukemia.
(PubMed, Leukemia)
- No abstract available.
Journal • PK/PD data
1 to 1
Of
1
Go to page
1